Anthracyclines induce DNA damage response-mediated protection against severe sepsis

Nuno Figueiredo, Angelo Chora, Helena Raquel, Nadja Pejanovic, Pedro Pereira, Björn Hartleben, Ana Neves-Costa, Catarina Moita, Dora Pedroso, Andreia Pinto, Sofia Marques, Hafeez Faridi, Paulo Costa, Raffaella Gozzelino, Jimmy L. Zhao, Miguel P. Soares, Margarida Gama-Carvalho, Jennifer Martinez, Qing-Shuo Zhang, Gerd DöringMarkus Grompe, J. Pedro Simas, Tobias B. Huber, David Baltimore, Vineet Gupta, Douglas R. Green, João A. Ferreira, Luis F. Moita

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates andlimited therapeutic options in addition to organ support measures. Here we show that the clinically approved group of anthracyclines acts therapeutically at a low dose regimen to confer robust protection against severe sepsis in mice. This salutary effect is strictly dependent on the activation of DNA damage response and autophagy pathways in the lung, as demonstrated by deletion of the ataxia telangiectasia mutated (Atm) or the autophagy-related protein 7 (Atg7) specifically in this organ. The protective effect of anthracyclines occurs irrespectively of pathogen burden, conferring disease tolerance to severe sepsis. These findings demonstrate that DNA damage responses, including the ATM and Fancony Anemia pathways, are important modulators of immune responses and might be exploited to confer protection to inflammation-driven conditions, including severe sepsis.

Original languageEnglish (US)
Pages (from-to)874-884
Number of pages11
JournalImmunity
Volume39
Issue number5
DOIs
StatePublished - Nov 14 2013

Fingerprint

Anthracyclines
DNA Damage
Sepsis
Ataxia Telangiectasia
Autophagy
Anemia
Inflammation
Lung
Mortality
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology
  • Medicine(all)

Cite this

Figueiredo, N., Chora, A., Raquel, H., Pejanovic, N., Pereira, P., Hartleben, B., ... Moita, L. F. (2013). Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity, 39(5), 874-884. https://doi.org/10.1016/j.immuni.2013.08.039

Anthracyclines induce DNA damage response-mediated protection against severe sepsis. / Figueiredo, Nuno; Chora, Angelo; Raquel, Helena; Pejanovic, Nadja; Pereira, Pedro; Hartleben, Björn; Neves-Costa, Ana; Moita, Catarina; Pedroso, Dora; Pinto, Andreia; Marques, Sofia; Faridi, Hafeez; Costa, Paulo; Gozzelino, Raffaella; Zhao, Jimmy L.; Soares, Miguel P.; Gama-Carvalho, Margarida; Martinez, Jennifer; Zhang, Qing-Shuo; Döring, Gerd; Grompe, Markus; Simas, J. Pedro; Huber, Tobias B.; Baltimore, David; Gupta, Vineet; Green, Douglas R.; Ferreira, João A.; Moita, Luis F.

In: Immunity, Vol. 39, No. 5, 14.11.2013, p. 874-884.

Research output: Contribution to journalArticle

Figueiredo, N, Chora, A, Raquel, H, Pejanovic, N, Pereira, P, Hartleben, B, Neves-Costa, A, Moita, C, Pedroso, D, Pinto, A, Marques, S, Faridi, H, Costa, P, Gozzelino, R, Zhao, JL, Soares, MP, Gama-Carvalho, M, Martinez, J, Zhang, Q-S, Döring, G, Grompe, M, Simas, JP, Huber, TB, Baltimore, D, Gupta, V, Green, DR, Ferreira, JA & Moita, LF 2013, 'Anthracyclines induce DNA damage response-mediated protection against severe sepsis', Immunity, vol. 39, no. 5, pp. 874-884. https://doi.org/10.1016/j.immuni.2013.08.039
Figueiredo N, Chora A, Raquel H, Pejanovic N, Pereira P, Hartleben B et al. Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity. 2013 Nov 14;39(5):874-884. https://doi.org/10.1016/j.immuni.2013.08.039
Figueiredo, Nuno ; Chora, Angelo ; Raquel, Helena ; Pejanovic, Nadja ; Pereira, Pedro ; Hartleben, Björn ; Neves-Costa, Ana ; Moita, Catarina ; Pedroso, Dora ; Pinto, Andreia ; Marques, Sofia ; Faridi, Hafeez ; Costa, Paulo ; Gozzelino, Raffaella ; Zhao, Jimmy L. ; Soares, Miguel P. ; Gama-Carvalho, Margarida ; Martinez, Jennifer ; Zhang, Qing-Shuo ; Döring, Gerd ; Grompe, Markus ; Simas, J. Pedro ; Huber, Tobias B. ; Baltimore, David ; Gupta, Vineet ; Green, Douglas R. ; Ferreira, João A. ; Moita, Luis F. / Anthracyclines induce DNA damage response-mediated protection against severe sepsis. In: Immunity. 2013 ; Vol. 39, No. 5. pp. 874-884.
@article{0e784fd14fdc4a1ca52e74ce255a0d69,
title = "Anthracyclines induce DNA damage response-mediated protection against severe sepsis",
abstract = "Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates andlimited therapeutic options in addition to organ support measures. Here we show that the clinically approved group of anthracyclines acts therapeutically at a low dose regimen to confer robust protection against severe sepsis in mice. This salutary effect is strictly dependent on the activation of DNA damage response and autophagy pathways in the lung, as demonstrated by deletion of the ataxia telangiectasia mutated (Atm) or the autophagy-related protein 7 (Atg7) specifically in this organ. The protective effect of anthracyclines occurs irrespectively of pathogen burden, conferring disease tolerance to severe sepsis. These findings demonstrate that DNA damage responses, including the ATM and Fancony Anemia pathways, are important modulators of immune responses and might be exploited to confer protection to inflammation-driven conditions, including severe sepsis.",
author = "Nuno Figueiredo and Angelo Chora and Helena Raquel and Nadja Pejanovic and Pedro Pereira and Bj{\"o}rn Hartleben and Ana Neves-Costa and Catarina Moita and Dora Pedroso and Andreia Pinto and Sofia Marques and Hafeez Faridi and Paulo Costa and Raffaella Gozzelino and Zhao, {Jimmy L.} and Soares, {Miguel P.} and Margarida Gama-Carvalho and Jennifer Martinez and Qing-Shuo Zhang and Gerd D{\"o}ring and Markus Grompe and Simas, {J. Pedro} and Huber, {Tobias B.} and David Baltimore and Vineet Gupta and Green, {Douglas R.} and Ferreira, {Jo{\~a}o A.} and Moita, {Luis F.}",
year = "2013",
month = "11",
day = "14",
doi = "10.1016/j.immuni.2013.08.039",
language = "English (US)",
volume = "39",
pages = "874--884",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Anthracyclines induce DNA damage response-mediated protection against severe sepsis

AU - Figueiredo, Nuno

AU - Chora, Angelo

AU - Raquel, Helena

AU - Pejanovic, Nadja

AU - Pereira, Pedro

AU - Hartleben, Björn

AU - Neves-Costa, Ana

AU - Moita, Catarina

AU - Pedroso, Dora

AU - Pinto, Andreia

AU - Marques, Sofia

AU - Faridi, Hafeez

AU - Costa, Paulo

AU - Gozzelino, Raffaella

AU - Zhao, Jimmy L.

AU - Soares, Miguel P.

AU - Gama-Carvalho, Margarida

AU - Martinez, Jennifer

AU - Zhang, Qing-Shuo

AU - Döring, Gerd

AU - Grompe, Markus

AU - Simas, J. Pedro

AU - Huber, Tobias B.

AU - Baltimore, David

AU - Gupta, Vineet

AU - Green, Douglas R.

AU - Ferreira, João A.

AU - Moita, Luis F.

PY - 2013/11/14

Y1 - 2013/11/14

N2 - Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates andlimited therapeutic options in addition to organ support measures. Here we show that the clinically approved group of anthracyclines acts therapeutically at a low dose regimen to confer robust protection against severe sepsis in mice. This salutary effect is strictly dependent on the activation of DNA damage response and autophagy pathways in the lung, as demonstrated by deletion of the ataxia telangiectasia mutated (Atm) or the autophagy-related protein 7 (Atg7) specifically in this organ. The protective effect of anthracyclines occurs irrespectively of pathogen burden, conferring disease tolerance to severe sepsis. These findings demonstrate that DNA damage responses, including the ATM and Fancony Anemia pathways, are important modulators of immune responses and might be exploited to confer protection to inflammation-driven conditions, including severe sepsis.

AB - Severe sepsis remains a poorly understood systemic inflammatory condition with high mortality rates andlimited therapeutic options in addition to organ support measures. Here we show that the clinically approved group of anthracyclines acts therapeutically at a low dose regimen to confer robust protection against severe sepsis in mice. This salutary effect is strictly dependent on the activation of DNA damage response and autophagy pathways in the lung, as demonstrated by deletion of the ataxia telangiectasia mutated (Atm) or the autophagy-related protein 7 (Atg7) specifically in this organ. The protective effect of anthracyclines occurs irrespectively of pathogen burden, conferring disease tolerance to severe sepsis. These findings demonstrate that DNA damage responses, including the ATM and Fancony Anemia pathways, are important modulators of immune responses and might be exploited to confer protection to inflammation-driven conditions, including severe sepsis.

UR - http://www.scopus.com/inward/record.url?scp=84887559345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887559345&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2013.08.039

DO - 10.1016/j.immuni.2013.08.039

M3 - Article

C2 - 24184056

AN - SCOPUS:84887559345

VL - 39

SP - 874

EP - 884

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 5

ER -